scholarly journals Surrogate Markers of Intestinal Inflammation in Paediatric Patients with Inflammatory Bowel Disease

Folia Medica ◽  
2020 ◽  
Vol 62 (2) ◽  
pp. 271-275
Author(s):  
Rayna Shentova ◽  
Mila Baycheva ◽  
Denitza Kofinova ◽  
Petio Hadjiiski ◽  
Penka Yaneva

Background: Endoscopic evaluation is the gold standard for monitoring the disease activity in inflammatory bowel disease (IBD) but the procedure is invasive and not appropriate for frequent use, especially in the paediatric population. The aim of the present study was to assess the correlation between the levels of several inflammatory biomarkers and the degree of intestinal inflammation in paediatric patients with IBD. Materials and methods: A single center study including 31 children with ulcerative colitis (UC) and 22 children with Crohn&rsquo;s disease (CD) with different disease duration and activity. All participants provided blood samples to measure the levels of white blood cell count, platelets, C-reactive protein, erythrocyte sedimentation rate, albumin and fibrinogen, and faecal samples for measurement of faecal calprotectin and faecal alpha-1 antitrypsin. All participants underwent endoscopic evaluation. Endoscopic disease activity was assessed according to the Mayo Endoscopic Subscore and Simple Endoscopic Score for Crohn&lsquo;s Disease in UC and CD patients, respectively. Results: 135 visits were included: 73 for UC patients and 62 for CD patients. In UC patients the strongest correlation was between the Mayo Endoscopic Subscore and the faecal calprotectin (r=0.867, p<0.001) followed by the albumin (r=0.523, p<0.001) and the&nbsp;C-reactive protein (r=0.487, p<0.001). In CD the strongest correlation was between the Simple Endoscopic Score for Crohn&rsquo;s disease and the faecal calprotectin (r=0.872, p<0.001) followed by the C-reactive protein (0.708, p<0.001) and the erythrocyte sedimentation rate (0.605, p<0.001). Conclusions: The faecal calprotectin is a valuable surrogate marker of intestinal inflammation that is useful for monitoring of a disease activity in paediatric patients with IBD.

2017 ◽  
Vol 53 (2) ◽  
pp. 91-96
Author(s):  
Katarzyna Lewandowska ◽  
Olga Ciepiela

Introduction: Calprotectin is an acute phase protein that occurs in large amounts in the granules and cytosolic fluid of neutrophils, and in smaller amounts in monocytes and macrophages. In bowel inflammation, increased neutrophil migration from the circulation to the intestinal lumen is observed as a consequence of mucosal damage. This leads to the release of a significant amount of calprotectin by activated leukocytes in intestine, thereby increasing its concentration in the faeces. This allows the non-invasive assessment of intestinal inflammation. Other markers useful in patients with bowel inflammation are erythrocyte sedimentation rate and C-reactive protein. Aim: The aim of the study was to evaluate the correlation between the concentration of faecal calprotectin (FC) and other markers of inflammation, such as C-reactive protein (CRP) and ferritin in serum, erythrocyte sedimentation rate (ESR) and white blood cells (WBC) count and in children with Crohn’s disease and ulcerative colitis. Material and methods: This study is based on a retrospective analysis of laboratory results of 370 children suspected of inflammatory bowel disease (IBD). Pearson’s coefficient was used to assess the correlation between the parameters. Results: There was a positive correlation between concentration of FC and parameters such as CRP (r=0.16; p=0.0345), ESR (r=0.38; p<0.0001) and WBC (r=0.24; p=0.0008) in children with IBD. There was also a negative correlation between concentration of FC and ferritin (r=-0.24; p=0.0089) in children with IBD. Conclusion: In this study, ESR turned out to be more adequate than CRP and WBC in detecting inflammation in patients with IBD.


2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Yi-Han Chen ◽  
Li Wang ◽  
Shu-Yi Feng ◽  
Wei-Min Cai ◽  
Xiao-Fu Chen ◽  
...  

Objectives. The aims of this study were to evaluate the C-reactive protein/albumin ratio (CRP/ALB), inflammatory markers, and parameters from the complete blood count (CBC) in patients with inflammatory bowel disease (IBD) and their associations with disease activity. Methods. A total of 876 IBD patients, composed of 275 patients with ulcerative colitis (UC) and 601 patients with Crohn’s disease (CD), were included in this retrospective study, and the serum C-reactive protein (CRP), albumin (ALB), erythrocyte sedimentation rate (ESR), and CBC parameters were measured. To explore the disease activity, the Mayo score and Crohn disease activity index were used to assess UC and CD patients, respectively. Results. The CRP/ALB ratio, CRP, ESR, platelet to lymphocyte ratio (PLR), red blood cell distribution width (RDW), and neutrophil to lymphocyte ratio (NLR) levels in active IBD patients were significantly higher than those in inactive IBD patients, whereas ALB and lymphocyte to monocyte ratio (LMR) levels were significantly decreased (P<0.001). The receiver operating characteristic analysis showed that the optimum cut-off values of the CRP/ALB ratio for active UC and CD were 0.18 and 0.43, with sensitivities of 67.8% and 75.8% and specificities of 86.7% and 92.0%, respectively. Multivariable logistic analysis revealed that after adjusting for these inflammatory markers (ESR, NLR, PLR, and LMR), the CRP/ALB ratio was a statistically significant parameter capable of differentiating the disease activity of UC and CD. Conclusions. This study indicated that the CRP/ALB ratio was closely related to the IBD disease activity. Compared with CBC parameters, the CRP/ALB ratio had a higher discriminative capacity for active IBD.


2015 ◽  
Vol 2015 ◽  
pp. 1-4 ◽  
Author(s):  
Zehra Betül Paköz ◽  
Cem Çekiç ◽  
Mahmut Arabul ◽  
Elif Sarıtaş Yüksel ◽  
Serkan İpek ◽  
...  

Aim. While there are many well-defined serological markers for inflammatory bowel disease (IBD), there is limited evidence that they positively affect clinical outcomes. This study aimed to evaluate the correlation between hepcidin serum levels and disease activity in IBD.Materials and Methods. Eighty-five consecutive IBD patients were enrolled in the study. Hepcidin serum levels were assessed using an enzyme-linked immunosorbent assay (ELISA) and were compared with disease activity as well as the interleukin-6 (IL-6) and C-reactive protein (CRP) levels.Results. The mean hepcidin serum levels in Crohn’s disease (CD) patients in remission and in the active phase were3837±1436and3752±1274 pg/mL, respectivelyP=0.613. The mean hepcidin serum levels in ulcerative colitis (UC) patients in remission and in the active phase were4285±8623and3727±1176 pg/mL, respectivelyP=0.241. Correlation analysis between inflammatory markers and hepcidin serum levels indicated that there was no correlation between hepcidin levels and IL-6P=0.582or CRPP=0.783.Conclusion. As an acute-phase protein, hepcidin seems to have a lower efficacy than other parameters in the detection of activation in IBD.


Sign in / Sign up

Export Citation Format

Share Document